Zdrowie i gospodarka · 19/03/1996
FDA Publishes Draft Guideline on Impurities in New Drug Products
The FDA is releasing a draft guideline on impurities in new drug products, developed under the International Conference on Harmonisation, to help pharmaceutical companies register and market their products
Source: Federal Register — Food and Drug AdministrationOpen original release →